SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending as escalating geopolitical tensions in the Middle East, driven by reports of US-Israeli strikes on Iran and subsequent retaliations, fuel widespread community discussion about potential oil supply disruptions, particularly regarding the Strait of Hormuz. Community sentiment is sharply divided between those anticipating a significant price surge and others expecting a rapid "sell the news" reversal.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending amidst escalating US-Iran conflict, with strikes on Gulf infrastructure and threats to the Strait of Hormuz fueling widespread fears of global oil supply disruptions and significant crude price surges. The community is actively discussing a flight to energy assets, positioning the sector for strong momentum even as broader markets anticipate risk-off sentiment.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending as escalating Middle East geopolitical tensions, including concerns over oil supply chokepoints like the Strait of Hormuz, are fueling community anticipation of surging crude prices and a potential short squeeze for this low-float energy stock.

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

MediWound Ltd

MediWound is trending as investors eagerly anticipate a potential BARDA contract for its burn treatment NexoBrid, which recently showed strong efficacy in blast injuries, alongside promising advancements for its EscharEx chronic wound therapy. This momentum, including institutional interest and buyout speculation, is driving conversation despite polarized views on the stock's ability to break through current trading ranges.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is trending amid enthusiasm for positive Phase 3 clinical trial results for its HER2-positive breast cancer drug and encouraging lung cancer therapy data, fueling community discussions about its oncology pipeline and strategic pivot, even as some debate recent analyst upgrades against news of a partner offloading its stake.

Global X Funds - Global X Silver Miners ETF

The Global X Silver Miners ETF is actively discussed amid a tightening physical silver supply and surging industrial demand from AI and EVs, fueling a "silver squeeze" narrative. Despite current frustration over miners lagging the metal's price surge, the community widely anticipates a significant catch-up rally, viewing the sector as historically undervalued.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is trending as intensifying geopolitical tensions in the Middle East, particularly regarding potential oil supply disruptions and the Strait of Hormuz, are driving crude prices higher. The community is actively discussing Chevron's strategic advantages, including expanded access to Venezuelan oil and new global exploration deals, positioning it for potential gains amid these market shifts.

Vanguard Group, Inc. - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

VOO is trending amidst heightened market uncertainty driven by Federal Reserve policy, geopolitical developments, and ongoing debates about the sustainability of valuations in the tech sector. Despite some community calls for a significant correction, many investors continue to favor VOO for its broad market exposure and long-term stability.

Crane Harbor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 2, 2025 and is headquartered in Philadelphia, PA.

Crane Harbor Acquisition Corp. - Ordinary Shares - Class A

Crane Harbor Acquisition Corp.

CHAC is gaining attention ahead of its imminent SPAC merger with Xanadu, a Canadian photonic quantum computing leader. The community is discussing Xanadu's pioneering room-temperature technology and its widely used PennyLane software, with many anticipating a significant rally for this unique pure-play in the quantum sector, though some note valuation concerns.

SSgA Active Trust - State Street Materials Select Sector SPDR ETF

Materials Select Sector SPDR Fund

The Materials Select Sector SPDR Fund is trending due to its strong leadership in a broad market rotation towards cyclical sectors, with community discussion focused on its breakout potential amidst rising commodity prices and robust industrial demand. Investors see XLB as a key beneficiary as other sectors like technology show signs of fatigue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tango Therapeutics (NASDAQ:TNGX) Insider Adam Crystal Sells 54,345 Shares

Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) insider Adam Crystal sold 54,345 shares of the stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an...

Adam Crystal Sells 54,345 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock

Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) insider Adam Crystal sold 54,345 shares of the company's stock in a transaction dated Wednesday, February 25th. The stock was sold at an...

Tango Therapeutics (NASDAQ:TNGX) Trading Down 10.4% - Here's What Happened

Tango Therapeutics (NASDAQ:TNGX) Trading Down 10.4% - Time to Sell...

RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View

Revolution Medicines posts a wider-than-expected Q4 loss and sees 2026 operating expenses of $1.6B-$1.7B as it advances late-stage RAS pipeline studies.

Tango Therapeutics (NASDAQ:TNGX) Hits New 1-Year High - Here's Why

Tango Therapeutics (NASDAQ:TNGX) Hits New 12-Month High - Time to Buy...

Tango Therapeutics (NASDAQ:TNGX) Trading Up 8.8% - Should You Buy?

Tango Therapeutics (NASDAQ:TNGX) Trading Up 8.8% - Here's What Happened...

Tango Therapeutics (NASDAQ:TNGX) Coverage Initiated at Mizuho

Mizuho initiated coverage on shares of Tango Therapeutics in a research note on Monday. They issued an "outperform" rating and a $19.00 target price for the company...

Tango Therapeutics (TNGX) to Release Earnings on Thursday

Tango Therapeutics (NASDAQ:TNGX) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Readystate Asset Management LP Trims Holdings in Tango Therapeutics, Inc. $TNGX

Readystate Asset Management LP reduced its stake in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 41.4% in the 3rd quarter, according to the company in its most recent filing with the...

Tango Therapeutics CEO Teases Pivotal Vopimetostat Trial, RAS Combo Data at Guggenheim Chat

Tango Therapeutics (NASDAQ:TNGX) is preparing to move further into late-stage development for its PRMT5 inhibitor vopimetostat, newly appointed CEO Malte Peters said during a Guggenheim fireside...

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.

Tango Therapeutics Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$11.14
Prev Close	$11.40
Open	$11.11
Dividend Yield	0.00%
50-Day Moving Average	$11.17
Beta	1.17
Avg. Volume	3.19M
PE Ratio	-12.15

52-Week High	$13.60
52-Week Low	$1.03
Market Capitalization	$1.5B
EPS (Annual)	-$1.19
Price to Book	7.77
Revenue Per Employee	$271,412.90

TNGX
Tango Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TNGX News

TNGXTango Therapeutics Inc